Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04975971 · ClinicalTrials.gov registry record
A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery
A clinical trial, sponsored by Nicole Fram M.D..
- Completed
- Registry status
- 25
- Enrollment target
NCT04975971 is a clinical trial that has completed, run by Nicole Fram M.D.. The registered enrollment target is 25 participants.
The verdict
NCT04975971 has completed, sponsored by Nicole Fram M.D..
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal transplant or Cataract surgery
Interventions
- DRUG Dextenza 0.4Mg Ophthalmic Insert
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2021-03-09 |
| Est. Completion | 2021-05-19 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04975971
The ClinicalTrials.gov registry entry for NCT04975971 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Nicole Fram M.D., which has 4 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Dextenza 0.4Mg Ophthalmic Insert is the first listed.
NCT04975971 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04975971 about?
NCT04975971 is a clinical study titled "A Retrospective Review of DEXTENZA 0.4 mg inseRt Following Corneal Transplant or Cataract Surgery". A Retrospective Review of Pain and Inflammation Resolution Outcomes in Patients Who Received DEXTENZA Intracanalicular Dexamethasone (0.4 mg) Insert Prior to or Following Corneal transplant or Cataract surgery
What is the current status of trial NCT04975971?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2021-03-09. Estimated completion is 2021-05-19.
What interventions are being tested in trial NCT04975971?
The interventions under investigation include: Dextenza 0.4Mg Ophthalmic Insert (DRUG).
Who is sponsoring clinical trial NCT04975971?
This trial is sponsored by Nicole Fram M.D., which has 4 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.